Biomedicines | Editor’s Choice Articles Published in 2023–2024 in the “Gene and Cell Therapy” Section

We are pleased to announce the selection of the Editor’s Choice Articles published in Biomedicines (ISSN: 2227-9059, latest Impact Factor 3.9, CiteScore 6.8) in the “Gene and Cell Therapy” Section. All of these papers have been selected by the Editorial Board Members from 2023 to 2024 and have been positively received by researchers; therefore, it is believed that they will interest readers and provide opportunities for follow-up research.

1. “Stem Cell Therapy for Myocardial Infarction Recovery: Advances, Challenges, and Future Directions”
by Nicholas T. Le, Matthew W. Dunleavy, William Zhou, Sumrithbir S. Bhatia, Rebecca D. Kumar, Suyin T. Woo, Gonzalo Ramirez-Pulido, Kaushik S. Ramakrishnan and Ahmed H. El-Hashash
Biomedicines 2025, 13(5), 1209; https://doi.org/10.3390/biomedicines13051209
Available online: https://www.mdpi.com/2227-9059/13/5/1209

2. “Salivary Proteome Insights: Evaluation of Saliva Preparation Methods in Mucopolysaccharidoses Research”
by Maria-Andreea Soporan, Ioana-Ecaterina Pralea, Maria Iacobescu, Radu Cristian Moldovan, Camelia Alkhzouz, Diana Miclea and Cristina-Adela Iuga
Biomedicines 2025, 13(3), 662; https://doi.org/10.3390/biomedicines13030662
Available online: https://www.mdpi.com/2227-9059/13/3/662

3. “Advances and Challenges in the Pursuit of Disease-Modifying Osteoarthritis Drugs: A Review of 2010–2024 Clinical Trials”
by Mckenzie D. Brandt, Jason B. Malone and Thomas J. Kean
Biomedicines 2025, 13(2), 355; https://doi.org/10.3390/biomedicines13020355
Available online: https://www.mdpi.com/2227-9059/13/2/355

4. “Structural Changes Likely Cause Chemical Differences between Empty and Full AAV Capsids”
by Caryn L. Heldt, Molly A. Skinner and Ganesh S. Anand
Biomedicines 2024, 12(9), 2128; https://doi.org/10.3390/biomedicines12092128
Available online: https://www.mdpi.com/2227-9059/12/9/2128

5. “Pathophysiology in Brain Arteriovenous Malformations: Focus on Endothelial Dysfunctions and Endothelial-to-Mesenchymal Transition”
by Jae Yeong Jeong, Adrian E. Bafor, Bridger H. Freeman, Peng R. Chen, Eun S. Park and Eunhee Kim
Biomedicines 2024, 12(8), 1795; https://doi.org/10.3390/biomedicines12081795
Available online: https://www.mdpi.com/2227-9059/12/8/1795

6. “DCTPP1 Expression as a Predictor of Chemotherapy Response in Luminal A Breast Cancer Patients”
by Juan P. Muñoz, Diego Soto-Jiménez and Gloria M. Calaf
Biomedicines 2024, 12(8), 1732; https://doi.org/10.3390/biomedicines12081732
Available online: https://www.mdpi.com/2227-9059/12/8/1732

7. “Cell-Based Treatment in Acute Myeloid Leukemia Relapsed after Allogeneic Stem Cell Transplantation”
by Martina Canichella and Paolo de Fabritiis
Biomedicines 2024, 12(8), 1721; https://doi.org/10.3390/biomedicines12081721
Available online: https://www.mdpi.com/2227-9059/12/8/1721

8. “The Kinetics of Inflammation-Related Proteins and Cytokines in Children Undergoing CAR-T Cell Therapy—Are They Biomarkers of Therapy-Related Toxicities?”
by Paweł Marschollek, Karolina Liszka, Monika Mielcarek-Siedziuk, Iwona Dachowska-Kałwak, Natalia Haze, Anna Panasiuk, Igor Olejnik, Tomasz Jarmoliński, Jowita Frączkiewicz, Zuzanna Gamrot et al.
Biomedicines 2024, 12(7), 1622; https://doi.org/10.3390/biomedicines12071622
Available online: https://www.mdpi.com/2227-9059/12/7/1622

9. “Biomarkers and Signaling Pathways Implicated in the Pathogenesis of Idiopathic Multicentric Castleman Disease/Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis, Renal Insufficiency, and Organomegaly (TAFRO) Syndrome”
by Remi Sumiyoshi, Tomohiro Koga and Atsushi Kawakami
Biomedicines 2024, 12(6), 1141; https://doi.org/10.3390/biomedicines12061141
Available online: https://www.mdpi.com/2227-9059/12/6/1141

10. “Long-Term Follow-up of Phase I Trial of Oncolytic Adenovirus-Mediated Cytotoxic and Interleukin-12 Gene Therapy for Treatment of Metastatic Pancreatic Cancer”
by Aseem Rai Bhatnagar, Farzan Siddiqui, Gazala Khan, Robert Pompa, David Kwon and Shyam Nyati
Biomedicines 2024, 12(5), 1065; https://doi.org/10.3390/biomedicines12051065
Available online: https://www.mdpi.com/2227-9059/12/5/1065

The following opportunities for collaboration may be of interest to you:

Submitting a manuscript:
The “Gene and Cell Therapy” Section is currently open for submissions. Papers may be submitted via the following link: https://www.mdpi.com/user/manuscripts/upload/?journal=biomedicines.

Joining the Volunteer Reviewer Board:
If you are an active researcher in the fields of biomedical research and are interested in joining the Volunteer Reviewer Board of Biomedicines, please do not hesitate to submit your application via the following link: https://susy.mdpi.com/volunteer/profile/edit.

Biomedicines Editorial Office